International contract research organisation ChemPartner has officially opened its first European scientific hub at Discovery Park. The company works with the biopharmaceutical industry to efficiently and rapidly bring life-changing drugs to market.
Founded in Shanghai in 2002, ChemPartner has more than 2,000 employees globally, most of whom are based in Asia. The company currently has seven UK employees, many of whom work hybrid, and is actively recruiting for a Senior Scientist to be based at Discovery Park.
ChemPartner’s Discovery Park facility is a dedicated centre for preclinical and translational research, supporting drug discovery with early-stage in vitro screening and allowing for increased operational agility and accelerated timelines. The new lab has been established in collaboration with Canterbury Christ Church University, through which ChemPartner is able to access advanced laboratory equipment onsite.
This new scientific hub marks the first step in ChemPartner’s broader UK and EU expansion, complementing the recent establishment of an R&D Centre of Excellence in Boston, USA, and the company’s established European administrative operations in Copenhagen, Denmark.
“Establishing our presence at Discovery Park reflects ChemPartner’s commitment to bringing high-quality science closer to our clients,” says Yinfei Yin, SVP of Biology, BD and Marketing. “This site enhances our ability to deliver responsive, integrated support across Europe, and we are excited to scale these capabilities alongside our partners.”
Mayer Schreiber, CEO at Discovery Park added: “ChemPartner is exactly the kind of globally ambitious business that Discovery Park was built for. The decision to establish a first European scientific hub here is a powerful endorsement of our community, and we look forward to being part of their growth story.”
ChemPartner marked the launch of its new hub with an opening event at Discovery Park on 10 April, attended by the Global Leadership team including William Woo, CEO and Chairman of ChemPartner.
